Namenda Switching Lawsuit May Go Actavis’ Way On Appeal
This article was originally published in The Pink Sheet Daily
Executive Summary
Oral arguments in Second Circuit attract overflow crowd in case that prompted amicus briefs from PhRMA, BIO and many others.